Leading Players in Latin America's Thriving In Vitro Diagnostics (IVD) Market
The Latin America In Vitro Diagnostics
(IVD) Market is set for substantial growth, with an anticipated Compound Annual
Growth Rate (CAGR) of 5.5% during the forecast period. This growth trajectory
is expected to propel the market from $4.44 billion in 2023 to a robust $6.45
billion by 2030, as per the latest report by 'Meticulous Research®'. The market
comprises consumables, such as kits & reagents, instruments, software, and
services. The surge is driven by factors like the increasing prevalence of both
communicable and non-communicable diseases, the rise of medical tourism, a
shift towards decentralized testing, and the growing awareness of early disease
diagnosis.
Top 10 companies that are at the
forefront of the Latin America In Vitro Diagnostics Market: https://meticulousblog.org/top-10-companies-in-latin-america-in-vitro-diagnostics-ivd-market/
1. F. Hoffmann-La Roche Ltd.
(Switzerland)
Established: 1896 Headquarters: Basel,
Switzerland
Key Offerings: Centralized and
point-of-care kits & reagents, advanced staining reagents, molecular
diagnostic tests, blood screening tests
Presence in Latin America: Argentina,
Bolivia, Brazil, Chile, Colombia, Dominican Republic, Ecuador, Mexico, and
more.
2. Abbott Laboratories (U.S.)
Established: 1888
Headquarters: Illinois, U.S.
Key Offerings: Diagnostics, medical
devices, nutrition, and branded generic pharmaceuticals
IVD Segments: Core Laboratory, Rapid
Diagnostics, Point of Care, Molecular
Global Reach: Operations across 90
manufacturing facilities
3. Danaher Corporation (U.S.)
Established: 1969
Headquarters: Washington, U.S.
Key Offerings: Analytical instruments,
reagents, consumables, software, and services for healthcare settings
IVD Segments: Clinical Lab Diagnostics,
Critical Care Diagnostics, Anatomical & Pathological Diagnostics
Global Footprint: 212 R&D,
manufacturing, sales, distribution, and service facilities in more than 60
countries worldwide
4. Siemens Healthineers AG (Germany)
Established: 1847
Headquarters: Erlangen, Germany
Key Offerings: Medical imaging, laboratory
diagnostics, point-of-care testing
Business Segments: Imaging, Diagnostics,
Varian, Advanced Therapies
Global Presence: Operations in more than
70 countries
5. Becton, Dickinson and Company
(U.S.)
Established: 1897
Headquarters: New Jersey, U.S.
Key Offerings: Medical supplies, devices,
laboratory equipment, and diagnostic products
Business Segments: BD Medical, BD Life
Sciences, BD Interventional
Broad Distribution: Presence in the U.S.,
Brazil, Canada, China, and more.
6. bioMérieux SA (France)
Established: 1963
Headquarters: Marcy l’Etoile, France
Key Offerings: Reagents, instruments, and
software for clinical diagnostics
Products: Used for infectious disease
diagnostics and detecting microorganisms in agri-food, pharmaceuticals, and
cosmetics
Global Network: Presence in 160 countries
through subsidiaries and production sites.
7. Thermo Fisher Scientific Inc.
(U.S.)
Established: 2006
Headquarters: Massachusetts, U.S.
Key Offerings: Analytical instruments,
laboratory equipment, laboratory services, and diagnostics instruments
IVD Solutions: Specialty Diagnostics
segment
Global Reach: Regional offices and
production sites in various countries.
8. QIAGEN N.V. (Netherlands)
Business Focus: Instruments, consumables,
and digital bioinformatics solutions for oncology, infectious diseases, and
more
Business Segments: Molecular Diagnostics
and Life Sciences
Broad Reach: Products sold to more than
500,000 customers in 35 countries.
9. Wama Diagnóstica (Brazil)
Specialization: Kits & reagents for
laboratory diagnostics, immunodiagnostics, and immuno-chromatographic tests
Certifications: ISO 13485, ISO 9001, GMP
Private Ownership: A privately held
company.
10. Wiener Laboratorios SAIC
(Argentina)
Offerings: Kits & analyzers for
clinical chemistry, hematology, coagulation, and immunology assays
Presence: Manufacturing facility in
Venezuela and affiliate companies in multiple Latin American countries.
Meticulous Research®'s latest report
predicts a growth rate of 5.5% in the Latin America In Vitro Diagnostics Market
for the period 2023-2030. The comprehensive report offers in-depth analysis of
each of these companies, covering financial performance, key products, company
strategies, partnerships, acquisitions, and more. It also provides global
market size estimates, market share analysis, revenue figures, and insights
into key industry trends and issues.
Top 10 Companies
in Latin America In Vitro Diagnostics (Ivd) Market : https://meticulousblog.org/top-10-companies-in-latin-america-in-vitro-diagnostics-ivd-market/
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment